1. Home
  2. EICC vs ORMP Comparison

EICC vs ORMP Comparison

Compare EICC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EICC

Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029

HOLD

Current Price

$25.32

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$2.73

Market Cap

104.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EICC
ORMP
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
104.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EICC
ORMP
Price
$25.32
$2.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.7K
243.2K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
7.96%
N/A
EPS Growth
N/A
838.25
EPS
0.55
1.03
Revenue
$51,224,692.00
$2,000,000.00
Revenue This Year
$39.61
N/A
Revenue Next Year
$27.28
N/A
P/E Ratio
$23.44
$2.65
Revenue Growth
68.61
N/A
52 Week Low
$23.75
$1.82
52 Week High
$25.25
$3.09

Technical Indicators

Market Signals
Indicator
EICC
ORMP
Relative Strength Index (RSI) 56.24 61.11
Support Level $25.25 $2.68
Resistance Level $25.34 $2.84
Average True Range (ATR) 0.10 0.15
MACD 0.01 0.02
Stochastic Oscillator 66.63 63.51

Price Performance

Historical Comparison
EICC
ORMP

About EICC Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: